Hudson Capital Management LLC Buys 191 Shares of Cigna Group $CI

Hudson Capital Management LLC raised its stake in Cigna Group (NYSE:CIFree Report) by 1.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 14,604 shares of the health services provider’s stock after purchasing an additional 191 shares during the quarter. Cigna Group accounts for 1.4% of Hudson Capital Management LLC’s portfolio, making the stock its 29th biggest position. Hudson Capital Management LLC’s holdings in Cigna Group were worth $4,828,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Family Legacy Inc. raised its holdings in shares of Cigna Group by 0.5% during the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after acquiring an additional 31 shares in the last quarter. Impact Investors Inc raised its holdings in shares of Cigna Group by 1.6% during the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after acquiring an additional 31 shares in the last quarter. Mission Wealth Management LP raised its holdings in shares of Cigna Group by 1.5% during the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after acquiring an additional 32 shares in the last quarter. Westend Capital Management LLC raised its holdings in shares of Cigna Group by 8.1% during the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after acquiring an additional 32 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC raised its holdings in shares of Cigna Group by 26.8% during the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after acquiring an additional 34 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 1.7%

NYSE CI opened at $295.60 on Tuesday. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The stock has a market cap of $78.90 billion, a P/E ratio of 16.14, a P/E/G ratio of 0.88 and a beta of 0.45. The stock’s fifty day moving average price is $295.25 and its 200-day moving average price is $308.92. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the prior year, the firm posted $6.72 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Insider Buying and Selling at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CI. Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Barclays increased their price objective on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Wells Fargo & Company increased their price objective on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Finally, TD Cowen upgraded Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $372.69.

View Our Latest Stock Report on CI

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.